Today, we celebrate Juneteenth, a day that commemorates the emancipation of enslaved African Americans and recognizes their enduring contributions to our nation’s history. As we honor this important milestone, let’s reflect on the significance of freedom, equality, and justice for all. To learn more about the historical legacy of Juneteenth, we encourage you to explore this insightful article by the National Museum of African American History and Culture #Juneteenth #FreedomDay #HistoryMatters #Equality
Neuron23
Biotechnology Research
South San Francisco, California 4,150 followers
We are a biotech company focused on developing precision medicines for neurological and immunological diseases.
About us
Neuron23™ Inc. is a leading clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The Company’s focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA.
- Website
-
https://neuron23.com
External link for Neuron23
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Privately Held
- Founded
- 2018
- Specialties
- biotech, precision medicine, immunological diseases, neurological diseases, neurodegenerative diseases, neuroinflammatory diseases, autoimmune diseases, inflammatory diseases, human genetics, data science, Parkinson's disease, Crohn's disease, Ulcerative colitis, psoriasis, IBD, and ankylosing spondylitis
Locations
-
Primary
343 Oyster Point Blvd
Suite 120
South San Francisco, California 94080, US
Employees at Neuron23
Updates
-
In our latest fireside chat, Andrew Yost, Chief Business Officer, shared that joining Neuron23 has been a pivotal moment in his career journey. “Throughout my career, I’ve always pursued opportunities that push me technically, creatively, and personally. Working at Neuron23 has allowed me to contribute to the advancement of cutting-edge science in areas of critical unmet medical need, while helping to build a sustainable company that can deliver on our mission to improve the lives of patients,” Andrew says. #FiresideChat #Neuron23 #WorkingAtN23 #Careers
-
-
Please join us in welcoming Eduardo Rojas , Senior Director Program Management at Neuron23. We're so excited to have you on board, Eduardo! #NewHires
-
-
Please join us in welcoming Anna Bakardjiev, MD, Vice President Clinical Development at Neuron23. We're so excited to have you on board, Anna! #NewHires
-
-
Please join us in welcoming Fatta B. Nahab MD, FAAN, FANA MD, Executive Director, Clinical and Digital Development at Neuron23. We're so excited to have you on board, Fatta! #NewHires
-
-
Grateful for the incredible turnout at Parkinson's Moving Day in San Jose! Let's continue to raise awareness and support for this important cause. #TeamSpirit #ParkinsonsAwareness
-
-
Neuron23 kicked off Parkinson’s Awareness Month by welcoming two visitors from Parkinson's Foundation to our office. The Foundation’s Rachel Howsmon outlined how the resources used by events like Moving Day support the Parkinson’s community, while Vikas Chinnan shared his journey as a Parkinson’s patient and advocate. All of us at Neuron23 are inspired by the work of Rachel, Vikas, and all the others dedicated to improving care and advancing research toward a cure. #ParkinsonsDisease #MovingDay #ParkinsonsFoundation
-
-
As Women’s History Month wraps up, Neuron23 is proud to announce the launch of its first internal diversity and inclusion focused employee group. Women at Neuron23 will enable our talented women and allies to support women in career development and networking leveraging efforts by organizations such as Women in Bio. Thanks to all the fantastic women at Neuron23 that bring their best every day to contribute to our mission. #WomensHistoryMonth #WomenInScience #WomenInBio
-
-
Neuron23 CEO Nancy Stagliano, Ph.D., will be participating in a fireside chat at the Stifel 2024 Virtual CNS Day on March 20, 2024. #CNS #ParkinsonsDisease #FiresideChat
-
-
Understanding human genetics and its role in disease is one of the key areas of research at Neuron23. As we celebrate International Women’s Day, we thought it would be interesting to look back on the often-underappreciated work of Rosalind Franklin who was instrumental in the co-discovery of the double-helix structure of DNA. #DNA #doublehelix #rosalindfranklin #internationalwomensday
Francis Crick, Rosalind Franklin, James Watson, and Maurice Wilkins
https://www.sciencehistory.org